Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...

You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...

The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...

There have been hundreds of cases of acute pancreatitis in people who have also taken Mounjaro, Ozempic and Wegovy.

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.

Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts ...

Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...

Both Wegovy and Ozempic are semaglutide – a drug that first entered the US market in 2017 as a diabetes medication. It was quickly hyped online as the secret to celebrities achieving extreme thinness.